Literature DB >> 33015751

Derivation of stable embryonic stem cell-like, but transcriptionally heterogenous, induced pluripotent stem cells from non-permissive mouse strains.

Tiffany A Garbutt1, Kranti Konganti2,3, Thomas Konneker1, Andrew Hillhouse2,3, Drake Phelps1, Alexis Jones1, David Aylor1, David W Threadgill4,5,6.   

Abstract

Genetic background is known to play a role in the ability to derive pluripotent, embryonic stem cells (ESC), a trait referred to as permissiveness. Previously we demonstrated that induced pluripotent stem cells (iPSC) can be readily derived from non-permissive mouse strains by addition of serum-based media supplemented with GSK3B and MEK inhibitors, termed 2iS media, 3 days into reprogramming. Here, we describe the derivation of second type of iPSC colony from non-permissive mouse strains that can be stably maintained independently of 2iS media. The resulting cells display transcriptional heterogeneity similar to that observed in ESC from permissive genetic backgrounds derived in conventional serum containing media supplemented with leukemia inhibitor factor. However, unlike previous studies that report exclusive subpopulations, we observe both exclusive and simultaneous expression of naive and primed cell surface markers. Herein, we explore shifts in pluripotency in the presence of 2iS and characterize heterogenous subpopulations to determine their pluripotent state and role in heterogenous iPSCs derived from the non-permissive NOD/ShiLtJ strain. We conclude that heterogeneity is a naturally occurring, necessary quality of stem cells that allows for the maintenance of pluripotency. This study further demonstrates the efficacy of the 2iS reprogramming technique. It is also the first study to derive stable ESC-like stem cells from the non-permissive NOD/ShiLtJ and WSB/EiJ strains, enabling easier and broader research possibilities into pluripotency for these and similar non-permissive mouse strains and species.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 33015751      PMCID: PMC9113365          DOI: 10.1007/s00335-020-09849-x

Source DB:  PubMed          Journal:  Mamm Genome        ISSN: 0938-8990            Impact factor:   3.224


  93 in total

1.  c-Myc is dispensable for direct reprogramming of mouse fibroblasts.

Authors:  Marius Wernig; Alexander Meissner; John P Cassady; Rudolf Jaenisch
Journal:  Cell Stem Cell       Date:  2007-12-13       Impact factor: 24.633

2.  PRDM14 ensures naive pluripotency through dual regulation of signaling and epigenetic pathways in mouse embryonic stem cells.

Authors:  Masashi Yamaji; Jun Ueda; Katsuhiko Hayashi; Hiroshi Ohta; Yukihiro Yabuta; Kazuki Kurimoto; Ryuichiro Nakato; Yasuhiro Yamada; Katsuhiko Shirahige; Mitinori Saitou
Journal:  Cell Stem Cell       Date:  2013-01-17       Impact factor: 24.633

3.  Derivation and characterization of mouse embryonic stem cells from permissive and nonpermissive strains.

Authors:  Anne Czechanski; Candice Byers; Ian Greenstein; Nadine Schrode; Leah Rae Donahue; Anna-Katerina Hadjantonakis; Laura G Reinholdt
Journal:  Nat Protoc       Date:  2014-02-06       Impact factor: 13.491

Review 4.  Embryo-derived stem cells: of mice and men.

Authors:  A G Smith
Journal:  Annu Rev Cell Dev Biol       Date:  2001       Impact factor: 13.827

5.  GSK-3 promotes conditional association of CREB and its coactivators with MEIS1 to facilitate HOX-mediated transcription and oncogenesis.

Authors:  Zhong Wang; Masayuki Iwasaki; Francesca Ficara; Chenwei Lin; Christina Matheny; Stephen H K Wong; Kevin S Smith; Michael L Cleary
Journal:  Cancer Cell       Date:  2010-06-15       Impact factor: 31.743

6.  Facilitators and impediments of the pluripotency reprogramming factors' initial engagement with the genome.

Authors:  Abdenour Soufi; Greg Donahue; Kenneth S Zaret
Journal:  Cell       Date:  2012-11-15       Impact factor: 41.582

Review 7.  Dual-specificity phosphatases: critical regulators with diverse cellular targets.

Authors:  Kate I Patterson; Tilman Brummer; Philippa M O'Brien; Roger J Daly
Journal:  Biochem J       Date:  2009-03-15       Impact factor: 3.857

8.  Prdm14 promotes germline fate and naive pluripotency by repressing FGF signalling and DNA methylation.

Authors:  Nils Grabole; Julia Tischler; Jamie A Hackett; Shinseog Kim; Fuchou Tang; Harry G Leitch; Erna Magnúsdóttir; M Azim Surani
Journal:  EMBO Rep       Date:  2013-05-14       Impact factor: 8.807

9.  Permissiveness to form pluripotent stem cells may be an evolutionarily derived characteristic in Mus musculus.

Authors:  Tiffany A Garbutt; Thomas I Konneker; Kranti Konganti; Andrew E Hillhouse; Francis Swift-Haire; Alexis Jones; Drake Phelps; David L Aylor; David W Threadgill
Journal:  Sci Rep       Date:  2018-10-02       Impact factor: 4.379

10.  Derivation of pluripotent epiblast stem cells from mammalian embryos.

Authors:  I Gabrielle M Brons; Lucy E Smithers; Matthew W B Trotter; Peter Rugg-Gunn; Bowen Sun; Susana M Chuva de Sousa Lopes; Sarah K Howlett; Amanda Clarkson; Lars Ahrlund-Richter; Roger A Pedersen; Ludovic Vallier
Journal:  Nature       Date:  2007-06-27       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.